A possible explanation might be related to the fact that miR-186-3p targets and binds to IGF1 and inhibits the activation of specific receptor tyrosine kinases (RTKs), thereby blocking the PI3K/AKT pathway, leading to increased apoptosis and decreased tumor formation, as shown in the present study (Figure 5). This evidence concerns the gene IGF1 and neoplasm.